Buy or sell Steep Hill Labs stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Steep Hill Labs Stock

Steep Hill Labs opened the first commercial cannabis lab in the United States in 2007.

Founded

2008

Notable Investors

Headquarters

Berkeley CA, US

Total Funding

$6.3M

About Steep Hill Labs Stock

Steep Hill Labs opened the first commercial cannabis lab in the United States in 2007. Now, with labs in 4 states (and at least two new locations opening in 2015), 5 Ph.D Scientists on staff and a recently-launched a state-of-the art Genetics Lab , Steep Hill is the country's leading cannabis analytical lab. In addition to its core testing business, Steep Hill is also innovative product development Lab that has already developed and commercialized two proprietary products: the QuantaCann and the GenKit. The QuantaCann is an on-site potency and moisture machine that provides important analytical information with respect to marijuana samples in 60 seconds. The QuantaCann was recently featured on CSI Vegas as the scientific equipment used to solve a murder in a marijuana dispensary. The QuantaCann has been approved as meeting the state requirements for the testing of potency, cannabinoid profiles and moisture by the State of New Mexico. The scientists at Steep Hill are busy developing the next generation of QuantaCann which will have no moving parts, an upgraded user interface, a wand for testing concentrates and other exciting features. The GenKit is the first product offering to come out of our Genetics Lab and was introduced to the market as of March 1, 2015. The GenKit contains 8 test packages which allow growers to clip a tiny portion of a seedling leaf and then send that package to the Lab. Once received, our geneticists are able to identify which plants are male plants. That information is then communicated to the customer through a convenient tracking system and the grower is then able to use this information to cull the male plants much sooner than could be done without the assistance of a genetics lab. This results in the saving of time, energy and resources and increased crop yield. Steep Hill is investing in its expansion, infrastructure and human capital to maintain its leadership position and to provide the best cannabis science.

Funding History

March 2015$3.3M
August 2015$1.0M
May 2017$2.0M

Management

Co-Founder & CEO

David Lampach

Co-Founder & Chief Business Development Officer

Addison DeMoura

General Counsel, Legal Officer

Mitch Kulick

Chief Operating Officer

Nigel Stobart

Chief Marketing Officer

John Yost

Outside Counsel

Erik Syvertsen

Co-Founder

Steve DeAngelo

Press

Other Companies

Logo
Addiction Campuses of America

Addiction Campuses of America owns, operates and manages behavioral healthcare campuses across the United States.

Logo
Epic Sciences

Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.

Logo
Mevion Medical Systems

Mevion Medical Systems

Logo
RefleXion Medical

The first biologically-guided radiation therapy for cancer.

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Steep Hill Labs or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo

Logo